Journal of International Oncology ›› 2014, Vol. 41 ›› Issue (10): 760-763.doi: 10.3760/cma.j.issn.1673422X.2014.10.013

Previous Articles     Next Articles

Her2 gene and breast cancer targeted therapy

 HUANG  Ling-Xiao, YAO  Wen-Xiu   

  1. Clinical College, Chongqing Medical University, Chongqing 400016, China
  • Online:2014-10-29 Published:2014-10-11
  • Contact: YaoWenxiu E-mail:ywxhlx@sina.com

Abstract: In recent years, with the development of tumor molecular biology technology, molecular targeted therapy has become a study hotspot, which plays a significant role on breast cancer treatment strategy. Among them, the human epidermal growth factor receptor2 (Her2) has been proven as an effective molecular target. So molecular targeted therapy of breast cancer become another important treatment except chemotherapy and endocrine therapy.

Key words: Breast neoplasms, Targeted therapy, Her2 gene